DoW Breast Cancer, Clinical Research Extension Award
Grant monitored from grants-gov.
- Buyer / agency
- Defense Health Agency Contracting Activity - DHACA
- Notice type
- Grant
- Solicitation number
- HT942526BCRPCREA2
- Posted
- September 3, 2026
- Response deadline
- November 18, 2026
- Location
- US
- Estimated value
- $8,400,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or …
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.